ORBIMED ADVISORS LLC

Holdings History for Passage BIO, Inc. - Common Stock, par value $0.0001 per share (PASG)

Symbol: PASG on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 7.4M shares
Security Ownership: 12%

Shares, Excluding Options vs Price

Value, Excluding Options

ORBIMED ADVISORS LLC ownership in Passage BIO, Inc. Common Stock, par value $0.0001 per share (PASG)

2024-12-26 - ORBIMED ADVISORS LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 7.4M shares of Passage BIO, Inc. Common Stock, par value $0.0001 per share (PASG). This represents 12% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
ORBIMED ADVISORS LLC	12%		$4.2M	7.4M			$0.57	13D/A	12/20/2024	26 Dec 2024 16:31:22

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024	0.09%	-0.03%	$4.2M	7.4M	-2,418,007	-24.6%	$0.57	Q4 2024
9/30/2024	0.13%	0%	$6.88M	9.82M	-301,700	-2.98%	$0.70	Q3 2024
6/30/2024	0.17%		$8.04M	10.1M			$0.79	Q2 2024
3/31/2024	0.25%		$13.7M	10.1M			$1.35	Q1 2024
12/31/2023	0.2%	+0.24%	$10.2M	10.1M	+10,124,576	NEW	$1.01	Q4 2023
9/30/2023	0.14%		$6.66M	10.1M			$0.66^*	Q3 2023
6/30/2023	0.17%	+0.02%	$9.53M	10.1M	+1,192,577	+13.4%	$0.94	Q2 2023
3/31/2023	0.17%		$8.55M	8.93M			$0.96	Q1 2023
12/31/2022	0.24%		$12.3M	8.93M			$1.38	Q4 2022
9/30/2022	0.21%		$11.2M	8.93M			$1.25	Q3 2022
6/30/2022	0.38%	+0.07%	$21.1M	8.93M	+1,600,000	+21.8%	$2.36	Q2 2022
3/31/2022	0.37%	+0.02%	$22.7M	7.33M	+369,100	+5.3%	$3.10	Q1 2022
12/31/2021	0.57%		$44.2M	6.96M			$6.35	Q4 2021
9/30/2021	0.76%		$69.4M	6.96M			$9.96	Q3 2021
6/30/2021	0.93%		$92.2M	6.96M			$13.24	Q2 2021
3/31/2021	1.14%		$122M	6.96M			$17.48	Q1 2021
12/31/2020	1.56%		$178M	6.96M			$25.57	Q4 2020
9/30/2020	1.15%		$91.3M	6.96M			$13.11	Q3 2020
6/30/2020	2.68%		$190M	6.96M			$27.33	Q2 2020
3/31/2020	1.84%	+1.84%	$110M	6.96M	+6,962,899	NEW	$15.75	Q1 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.